FDA Drug · D-0117-2025

Javygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 Made in India, NDC 43598-096-04.

Class III · Ongoing

Failed Impurities/Degradation Specifications

Advertisement
Advertisement
Affected lots / codes — check yours against thisLot #: T2300653, Exp 01/31/2025; T2303956, T2303750, Exp 06/30/2025; T2304190, T2304987, Exp 08/31/2025; T2302026, Exp 03/31/2025; T2302526, Exp 05/31/2025.
Recalling firm
Dr. Reddy's Laboratories, Inc., Princeton, NJ
Classification
Class III (unlikely to cause harm)
Status
Ongoing
Quantity
7,233 bottles
Distribution
U.S. Nationwide
Recall initiated
November 22, 2024
Classified
December 12, 2024
Initiation
Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0117-2025%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →